Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastomaGonzalo López, Sharon J. Diskin, Lance M. Farra et al.|Genome Research|2020Cited by 32
Germline pathogenic variants in neuroblastoma patients are enriched in <i>BARD1</i> and predict worse survivalJung Kim, Sharon J. Diskin, Zalman Vaksman et al.|JNCI Journal of the National Cancer Institute|2023Cited by 28
Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastomaGonzalo López, Sharon J. Diskin, Karina L. Conkrite et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 1